VEGF −2578CC and −1498TT genotypes decreased the hypertension toxicity of BEV in Japanese CRC patients [31], but these two SNPs had no association with the outcome of CRC patients treated with BEV-based chemotherapy [32]. This evidence concerns the gene VEGFA and Hypertension.